Related Experiment Video
Updated: Jun 4, 2026
10:27
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Novel trends in celiac disease.
Torsten Matthias1, Sandra Neidhöfer, Sascha Pfeiffer
1AESKU.KIPP Institute, Wendelsheim, Germany. matthias@aesku-kipp.com
Cellular & Molecular Immunology
|February 1, 2011
Summary
Celiac disease (CD) diagnosis can be improved using novel celiac neo-epitopes. These markers, formed by gliadin peptides and transglutaminase (tTg), offer earlier detection than traditional methods for celiac disease.
Area of Science:
- Gastroenterology
- Immunology
- Biochemistry
Background:
- Celiac disease (CD) is a prevalent food intolerance affecting genetically predisposed individuals.
- Undiagnosed CD can lead to severe health consequences.
- Despite being known for over a century, CD remains a significant research focus.
Purpose of the Study:
- To improve diagnostic methods for celiac disease.
- To identify and utilize novel biomarkers for earlier CD detection.
Main Methods:
- Investigated the pathomechanism of gluten processing and antigen presentation in CD.
- Developed diagnostic antigens mimicking the primary epitope in CD, termed celiac neo-epitopes.
- Characterized celiac neo-epitopes as a complex of gliadin peptides crosslinked with tissue transglutaminase (tTg).
Main Results:
- Celiac neo-epitopes serve as an early diagnostic marker for CD.
- These markers can be detected up to six months earlier than classical CD markers.
- Classical diagnostic markers may miss a certain proportion of CD patients.
Conclusions:
- Celiac neo-epitopes represent a significant advancement in CD diagnostics.
- The use of celiac neo-epitopes can lead to earlier diagnosis and management of celiac disease.
- Multidisciplinary collaboration is crucial for improving patient outcomes in CD.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:20Taste Buds and Receptors
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...